Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 12:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 188 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Fractional Clear all

Conditions: Burn Scar, Hypertrophic Scarring, Procedural Sedation
Interventions: Remimazolam besylate, Propofol; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Skin Resurfacing, Wrinkle Reduction
Interventions: Fractional RF treatment with Matrix RF applicator; Device
Lead sponsor: Syneron Medical; Industry
Eligibility: 21 Years and older
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 2
States / cities: Lincolnshire, Illinois • Chesterfield, Missouri

Conditions: Female Pattern Baldness
Interventions: 1550nm non-ablative fractional laser, 1927 thulium fractional laser; Device
Lead sponsor: Goldman, Butterwick, Fitzpatrick and Groff; Other
Eligibility: 35 Years to 65 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: San Diego, California

Conditions: Vulvodynia
Interventions: CO2 laser, Lidocaine patch 5%; Device · Drug
Lead sponsor: Atlantic Health System; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Denville, New Jersey

Conditions: Stress Urinary Incontinence, Vulvovaginal Signs and Symptoms
Interventions: MorpheusV Applicator; Device
Lead sponsor: InMode MD Ltd.; Industry
Eligibility: 35 Years to 75 Years · Female only
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Alpharetta, Georgia • Bluffton, South Carolina

Conditions: Acne Scarring
Interventions: Fractionated Laser Resurfacing; Procedure
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 59 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Skin Laxity (Submental and Neck), Skin Lifting and Tightening
Interventions: 2910 nm fiber laser (UltraClear®); Device
Lead sponsor: FA Corporation; Industry
Eligibility: 35 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Prospect, Kentucky • Houston, Texas

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 40 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Wrinkle
Interventions: Tixel, Laser; Device
Lead sponsor: Novoxel Ltd.; Industry
Eligibility: 40 Years to 70 Years
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Photoaging, Wrinkle, Skin Laxity
Interventions: Fractional Ablative CO2 Laser, Facial Cleanser, Facial Moisturizer, Sunscreen, Basic Ointment; Procedure · Other
Lead sponsor: Revision Skincare; Industry
Eligibility: 35 Years to 65 Years · Female only
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Blue Ash, Ohio

Conditions: Osteoporosis
Interventions: rhPTH(1-34), SB-751689 100 mg, SB-751689 400 mg; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 5
States / cities: San Diego, California • Daytona Beach, Florida • Port Orange, Florida + 2 more

Conditions: Scars, Scleroderma
Interventions: Laser Treatment; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Skin Aging
Interventions: Erbium laser; Device
Lead sponsor: Palomar Medical Technologies, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 5
States / cities: San Diego, California • Burlington, Massachusetts • Concord, Massachusetts + 2 more

Conditions: Wrinkle, Rhytides, Histopathology
Interventions: ellacor® Micro-Coring procedure; Device
Lead sponsor: Cytrellis Biosystems, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Atherosclerosis, Coronary
Interventions: CCTA; Diagnostic Test
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Skin Cancer
Interventions: Laser Treatment; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Coronary Artery Disease
Interventions: ComboMap XT Guidewire, 'SPY' NIRF During CABG; Device · Procedure
Lead sponsor: East Carolina University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Greenville, North Carolina

Conditions: Skin Laxity
Interventions: Focal Contouring System; Device
Lead sponsor: Recros Medica, Inc.; Industry
Eligibility: 30 Years and older
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 14
States / cities: Campbell, California • Encino, California • Los Angeles, California + 11 more

Conditions: Coronary Artery Disease, Acute Coronary Syndrome
Interventions: Fractional Flow Reserve; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 2,217 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 4
States / cities: Huntsville, Alabama • Orlando, Florida • Decatur, Georgia + 1 more

Conditions: Coronary Artery Disease
Interventions: adenosine, regadenoson; Drug
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Jacksonville, Florida • St Louis, Missouri

Conditions: Leg Ulcer
Interventions: CO2RE® (Syneron Candela Corp, Wayland, MA), Sham laser treatment; Device · Other
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: St Louis, Missouri

Conditions: Acne Scars
Interventions: Venus Viva; Device
Lead sponsor: Venus Concept; Industry
Eligibility: 22 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Port Orange, Florida

Conditions: Cicatrix, Carbon Dioxide Laser
Interventions: Syneron-Candela CO2RE Laser; Device
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Scars
Interventions: Tixel C; Device
Lead sponsor: Novoxel Ltd.; Industry
Eligibility: 18 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Remimazolam vs Propofol in Laser Burn Cases

Clinical Study to Evaluate the Performance of Fractional Radiofrequency for Improvement of Skin Texture Via Skin Resurfacing and Wrinkles Reduction

1550nm Non-ablative Fractional Vs 1927nm Thulium Fractional Laser for the Treatment of Female Pattern Hair Loss

CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women

Clinical Evaluation of Fractional Bi-Polar RF for Symptoms of SUI and Vulvovaginal Atrophy

Safety and Efficacy of 1550nm Fractional Laser Treatment for Acne Scars in Fitzpatrick Type IV-VI Skin

Safety and Efficacy of a 2,910 nm Fractional Ablative Fiber Laser (UltraClear®) for Improvements of Skin Laxity and Lifting of the Lower Face, Submental, and Neck Treatment Areas

Functional Assessment of Coronary Artery Disease by CTA Flow Encoding

A Safety and Effectiveness Study of the Tixel Device, (Fractional Peri-orbital Wrinkles Treatment ) Compared With Laser

Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation

A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women

Laser Treatment for the Improvement of Scars and Scleroderma

Safety and Efficacy Evaluation of Erbium Treatment

Healing Study of Fractional Skin Resurfacing and Tissue Histopathology After Ellacor Treatment

Validation of a Computed Tomography (CT) Based Fractional Flow Reserve (FFR) Software Using the 320 Detector Aquilion ONE CT Scanner.

Post Excision/Mohs Scar Laser Resurfacing

Correlation Study of Imaging Data Acquired During CABG With Data Acquired in the Cath Lab

The INFORM Study: Rotational Fractional Resection for Submental Contouring

PRESSUREwire Study

Comparison of Intravenous Adenosine Infusion With Regadenoson Bolus for Inducing Maximal Coronary Hyperemia

Evaluating the Safety and Efficacy of Fractionated Carbon Dioxide Therapy in Postoperative Lower Extremity Wound Healing

Clinical Evaluation of Fractional Radiofrequency for the Treatment of Acne Scarring

Interventional Study to Evaluate the Appearance of Surgical Scars After Laser Therapy

Clinical Study to Evaluate the Safety and Effectiveness of the Treatment With Tixel C on Acne Scars